Published on Web 08/28/2009
Mesomorphic Imidazolium Salts: New Vectors for Efficient
siRNA Transfection
William Dobbs,† Benoˆıt Heinrich,† Cyril Bourgogne,† Bertrand Donnio,†
Emmanuel Terazzi,† Marie-Elise Bonnet,‡ Fabrice Stock,‡ Patrick Erbacher,‡
Anne-Laure Bolcato-Bellemin,‡ and Laurent Douce*,†
Institut de Physique et Chimie des Mate´riaux de Strasbourg, UMR 7504, CNRS-UniVersite´ de
Strasbourg, BP 43, 23 rue du Loess, F-67034 Strasbourg Cedex 2, France, and
Polyplus-transfection, BIOPARC, BouleVard Se´bastien Brandt, BP 90018, 67401 Illkrich, France
Received April 21, 2009; E-mail: Laurent.Douce@ipcms.u-strasbg.fr
Abstract: The preparation of chloride (1n) and bromide (2n) derivatives of 1-methyl-3-[3,4-bis(alkoxy)benzyl]-
4H-imidazolium with n ) 6, 12, 16, 18 is described. The two series of salts possess a rich thermotropic
j
mesomorphism, chain-length dependent. Thus, a lamellar smectic A phase, a bicontinuous cubic Ia3d
phase, and a columnar hexagonal liquid crystalline mesophase are induced as a function of increasing
chain length. The mesomorphic properties were studied by polarizing optical microscopy, differential scanning
calorimetry, and X-ray diffraction, and with the support of dilatometry and molecular dynamics, models for
the various supramolecular arrangements of the salts are proposed. Such cationic amphiphiles were
expected to be candidate molecules to design a new delivery reagent for nucleic acid transfection, particularly
for short interfering RNA (siRNA). The use of an RNA interference mechanism, by introduction into cells
by transfection of chemically synthesized siRNAs, is a powerful method for gene silencing studies. To
exploite the potential of these amphilic imidazolium salts, these molecules were formulated with cohelper
lipids and tested for their efficacy to deliver active siRNAs. Our results show high transfection efficacy of
our formulated compounds and high silencing efficiency with more than 80% inhibition of the targeted
gene at 10 nM siRNA concentration. Taken together our results show the potency of amphiphilic imidazolium
salts as a new generation of transfection reagents for RNA interference.
DNA being one example, by Coulombic interactions.2 The
description of cationic amphiphiles active as nucleic acid
transfection agents,3 in particular, has sparked major interest
within the scientific community.4 An important application of
this procedure, defined recently by A. Z. Fire and C. C. Mello,5
concerns the fact that double-stranded RNA triggers suppression
of gene activity in a homology-dependent manner, the RNA
interference (RNAi) process. The ability of RNAi to dramatically
and selectively reduce the expression of an individual protein
in a cell makes RNAi a valuable laboratory tool, both in cell
culture and in ViVo. Furthermore, RNAi protects against RNA
virus infections, especially in plants and invertebrate animals,
1. Introduction
Uniting the properties of ionic derivativesstheir low melting
points, low volatility, nonflammability, high chemical and
radiochemical stability, tunable conductivity, and wide electro-
chemical windowsswith those of liquid crystals, with their
many forms of labile macroscopic ordering, raises fascinating
prospects. This combination could lead to a vast range of new
multifunctional materials.1 Ionic molecules have also attracted
much attention in the fields of biorelated sciences, a major reason
for this interest being the ability of appropriate cationic
compounds to form liposomes able to confine anionic species,
(2) (a) Ra¨dler, J. O.; Koltover, I.; Salditt, T.; Safinya, C. R. Science 1997,
275, 810–814. (b) Cui, L.; Zhu, L. Lamgnuir 2006, 5982–5985. (c)
Miller, A. D. Angew. Chem., Int. Ed. 1998, 37, 1768–1785. (d) Cui,
L.; Miao, J.; Zhu, L. Macromolecules 2006, 39, 2536–2545. (e) Joester,
D.; Losson, M.; Pugin, R.; Heinzelmann, H.; Walter, E.; Merkle, H. P.;
Diederich, F. Angew. Chem., Int. Ed. 2003, 42, 1486–1490.
(3) (a) Huang, Q.-D.; Chen, H.; Zhou, L.-H.; Huang, J.; Wu, J.; Yu, X.-
Q. Chem. Bio. Drug Des. 2008, 71, 224–229. (b) Ito, A.; Miyazoe,
R.; Mitoma, J.; Akao, T.; Osaki, T.; Kunitake, T. Biochem. Int. 1990,
22, 235–241. (c) van der Woude, I.; Wagenaar, A.; Meekel, A. A.;
ter Beest, M. B.; Ruiters, M. H.; Engberts, J. B.; Hoekstra, D. Proc.
Natl. Acad. Sci. U.S.A. 1997, 94, 1160–1165. (d) Zhang, S.; Zhao,
B.; Jiang, H.; Wang, B.; Ma, B. J. Controlled Release 2007, 123,
1–10.
† CNRS-Universite´ de Strasbourg.
‡ Polyplus-transfection.
(1) (a) Wasserscheid, P.; Welton, T. Ionic Liquids in Synthesis; Wiley-
VCH: Weinheim, 2003. (b) Dupont, J.; de Souza, R. F.; Suarez, P. A.
Chem. ReV. 2002, 102, 3667–3692. (c) Song, C. E. Chem. Commun.
2004, 1033–1043. (d) Ohno, H. Electrochemical Aspects of Ionic
Liquids; Wiley-Interscience: 2005. (e) Crosthwaite, J. M.; Aki,
S. N. V. K.; Maginn, E. J.; Brennecke, J. F. J. Phys. Chem. B 2004,
108, 5113–5119. (f) Yoshizawa, M.; Xu, W.; Angell, C. A. J. Am.
Chem. Soc. 2003, 125, 15411–15419. (g) Fry, A. J. J. Electroanal.
Chem. 2003, 546, 35–39. (h) Ionic Liquids IIIA: Fundamental,
Progress, Challenges and Opportunities; Rogers, R. B., Seddon, K. R.,
Eds.; ACS Symposium Series 901; American Chemical Society:
Washington DC, 2005. (i) Ionic Liquids IIIB: Fundamental, Progress,
Challenges and Opportunities; Rogers, R. B., Seddon, K. R., Eds.;
ACS Symposium Series 902; American Chemical Society: Washington
DC, 2005.
(4) (a) Aigner, A. Curr. Opin. Mol. Ther. 2007, 9, 345–352. (b) Li, W.;
Szoka, F. C. Pharm. Res. 2007, 24, 438–49.
(5) (a) Fire, A. Z. Angew. Chem., Int. Ed. 2007, 46, 37, 6966–6984. (b)
Mello, C. C. Angew. Chem., Int. Ed. 2007, 46, 37, 6985–6994.
9
13338 J. AM. CHEM. SOC. 2009, 131, 13338–13346
10.1021/ja903028f CCC: $40.75 2009 American Chemical Society